Janssen-Cilag

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Roel Boons",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "PwC Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering heeft beslist om, op voordracht van de Ondernemingsraad, het mandaat van de commissaris, PwC Bedrijfsrevisoren BV, te hernieuwen voor een termijn van drie boekjaren, waarvan het eerste eindigt op 31 december 2025. Deze vennootschap heeft Roel Boons, bedrijfsrevisor, aangeduid"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "facts": [
    {
      "date": "2025-04-04",
      "type": "publication",
      "quote": "04/04/2025",
      "value": "04/04/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "date": null,
      "type": "filing",
      "quote": "neergelegd/ontvangen op 28 MAIT 2025",
      "value": "28/05/2025",
      "object": null,
      "subject": "e1",
      "date_suspect": "2025-05-28"
    },
    {
      "date": "2025-02-07",
      "type": "permanent_representative",
      "quote": "Janssen-Cilag N.V. (BE 0415.283.427) heeft als nieuwe vaste vertegenwoordiger vanaf 07/02/2025 mevrouw Roxana Botea",
      "value": {
        "start_date": "07/02/2025"
      },
      "object": "e2",
      "subject": "e3"
    },
    {
      "date": "2025-02-01",
      "type": "permanent_representative",
      "quote": "Pfizer N.V. (BE 0401.994.823) hepft als nieuwe vaste vertegenwoordiger vanaf 01/02/2025 de heer David Lepoittevin",
      "value": {
        "start_date": "01/02/2025"
      },
      "object": "e5",
      "subject": "e6"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "postfix": [
      "filing date 2025-05-28 outside [pub-60d, pub] -\u003E nulled (garbled stamp?)"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1313,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Kantersteen 47, 1000 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Roxana Botea",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Marleen Hoebus",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer N.V.",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "David Lepoittevin",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "An Van Gerven",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "date": "2025-04-04",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 04/04/2025",
      "value": "04/04/2025",
      "object": null,
      "subject": null
    },
    {
      "date": "2025-03-28",
      "type": "filing",
      "quote": "naergelegd/ontvangen.o\u0440 28 MAART 2025",
      "value": "28/03/2025",
      "object": null,
      "subject": null
    },
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Nomination nouveaux repr\u00E9sentants permanents des administrateurs",
      "value": "Nomination nouveaux repr\u00E9sentants permanents des administrateurs",
      "object": null,
      "subject": null
    },
    {
      "date": "2025-02-07",
      "type": "permanent_representative",
      "quote": "Janssen-Cilag S.A. (BE 0415.283.427) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 07/02/2025 Madame Roxana Botea",
      "value": {
        "start_date": "07/02/2025"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2025-02-01",
      "type": "permanent_representative",
      "quote": "Pfizer S.A. (BE 0401.994.823) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 01/02/2025 Monsieur David Lepoittevin",
      "value": {
        "start_date": "01/02/2025"
      },
      "object": "e3",
      "subject": "e4"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1329,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {}
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Roxana Botea",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "David Lepoittevin",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Benoeming Ondervoorzitter Raad van Bestuur - nieuwe vaste vertegenwoordigers Raad van bestuur - wijziging statuten",
      "value": "Benoeming Ondervoorzitter Raad van Bestuur - nieuwe vaste vertegenwoordigers Raad van bestuur - wijziging statuten",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-01-03",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 03/01/2025 - Annexes du Moniteur belge",
      "value": "03/01/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-12-23",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 23 12 2024",
      "value": "23/12/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-10-16",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 16 OKTOBER 2024",
      "value": "16/10/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-10-16",
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 16 oktober 2024 werd de heer Xavier Hormaechea tot ondervoorzitter van de Raad van Bestuur benoemd.",
      "value": {
        "role": "ondervoorzitter van de Raad van Bestuur",
        "start_date": "2024-10-16"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "ondervoorzitter van de Raad van Bestuur",
        "term": null,
        "start_date": "16/10/2024"
      }
    },
    {
      "date": "2024-09-25",
      "type": "permanent_representative",
      "quote": "Janssen-Cilag N.V. (BE 0415.283.427) heeft als nieuwe vaste vertegenwoordiger vanaf 25/09/2024 mevrouw Marleen Hoebus in opvolging van mevrouw Maria Prado.",
      "value": {
        "start_date": "25/09/2024"
      },
      "object": "e3",
      "subject": "e4"
    },
    {
      "date": "2024-10-01",
      "type": "permanent_representative",
      "quote": "Amgen N.V. (BE 0439.652.401) heeft als nieuwe vaste vertegenwoordiger vanaf 01/10/2024 mevrouw Sara Schaufelberger in opvolging van de heer Gabor Sztaniszlav.",
      "value": {
        "start_date": "01/10/2024"
      },
      "object": "e6",
      "subject": "e7"
    },
    {
      "date": "2024-11-14",
      "type": "permanent_representative",
      "quote": "AstraZeneca N.V. (BE 0400.165.679) heeft als nieuwe vaste vertegenwoordiger vanaf 14/11/2024 mevrouw Angela Thompson in opvolging van mevrouw Keira Driansky.",
      "value": {
        "start_date": "14/11/2024"
      },
      "object": "e9",
      "subject": "e10"
    },
    {
      "date": "2024-11-27",
      "type": "general_meeting",
      "quote": "BUITENGEWONE ALGEMENE VERGADERING VAN 27 NOVEMBER 2024",
      "value": "27/11/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "statute_amendment",
      "quote": "De voorgestelde wijzigingen aan de statuten werden goedgekeurd door de Buitengewone Algemene Vergadering van 27 november 2024",
      "value": {
        "description": "Wijziging statuten goedgekeurd door Buitengewone Algemene Vergadering van 27 november 2024, inclusief artikelen 5, 6, 7, 8, 9, 13, 16, 22, 24, 28 en overgangsbepalingen."
      },
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 41579,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "org",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Kantersteen 47, 1000 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Xavier Hormaechea",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Marleen Hoebus",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Maria Prado",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen N.V.",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Sara Schaufelberger",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Gabor Sztaniszlav",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca N.V.",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Angela Thompson",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Keira Driansky",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "date": "2025-01-03",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 03/01/2025 - Annexes du Moniteur belge",
      "value": "03/01/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-12-23",
      "type": "filing",
      "quote": "neergelegd\u0027ontvangan op 23 DEC. 2024",
      "value": "23/12/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-10-16",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 16 OCTOBRE 2024",
      "value": "16/10/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-10-16",
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 16 octobre 2024, Monsieur Xavier Hormaechea a \u00E9t\u00E9 d\u00E9sign\u00E9 comme Vice-Pr\u00E9sident.",
      "value": {
        "role": "Vice-Pr\u00E9sident",
        "start_date": "2024-10-16"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "Vice-Pr\u00E9sident",
        "term": null,
        "start_date": "16/10/2024"
      }
    },
    {
      "date": "2024-09-25",
      "type": "permanent_representative",
      "quote": "Janssen-Cilag S.A. (BE 0415.283.427) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 25/09/2024 Madame Marleen Hoebus, succ\u00E9dant \u00E0 Madame Maria Prado.",
      "value": {
        "start_date": "25/09/2024"
      },
      "object": "e3",
      "subject": "e4"
    },
    {
      "date": "2024-10-01",
      "type": "permanent_representative",
      "quote": "Amgen S.A. (BE 0439.652.401) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 01/10/2024 Madame Sara Schaufelberger, succ\u00E9dant \u00E0 Monsieur Gabor Sztaniszlav.",
      "value": {
        "start_date": "01/10/2024"
      },
      "object": "e6",
      "subject": "e7"
    },
    {
      "date": "2024-11-14",
      "type": "permanent_representative",
      "quote": "AstraZeneca S.A. (BE 0400.165.679) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 14/11/2024 Madame Angela Thompson, succ\u00E9dant \u00E0 Madame Keira Driansky.",
      "value": {
        "start_date": "14/11/2024"
      },
      "object": "e9",
      "subject": "e10"
    },
    {
      "date": "2024-11-27",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE EXTRAORDINAIRE DU 27 NOVEMBRE 2024",
      "value": "27/11/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "statute_amendment",
      "quote": "Les modifications propos\u00E9es aux statuts ont \u00E9t\u00E9 approuv\u00E9es par l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire du 27 novembre 2024",
      "value": {
        "description": "Modifications aux statuts approuv\u00E9es par l\u0027AGE du 27 novembre 2024, incluant les articles 5 (Admission), 6 (D\u00E9mission), 7 (Exclusion), 8 (D\u00E9mission - Exclusion), 9 (Repr\u00E9sentation), 13 (Convocations), 16 (Composition), 22 (Proc\u00E9dure), 24 (R\u00E8glement d\u0027ordre int\u00E9rieur), 28 (Cotisations) et dispositions transitoires."
      },
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 41680,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "org",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "Cantersteen 47, 1000 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Xavier Hormaechea",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Marleen Hoebus",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Maria Prado",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen S.A.",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Sara Schaufelberger",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Gabor Sztaniszlav",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca S.A.",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Angela Thompson",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Keira Driansky",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Maria Fernanda Prado",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-08-01",
      "evidence_quote": "AKTE GENOMEN van het ontslag van Maria Fermanda Prado als bestuurder en gedelegeerd bestuurder van de vennootschap met ingang vanaf 1 augustus 2024 wegens het opnemen van andere verantwoordelijkheden binnen de Johnson \u0026 Johnson groep van vennootschappen.",
      "discharge_granted": false
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Maria Fernanda Prado",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-08-01",
      "evidence_quote": "De raad van bestuur NEEMT AKTE van het ontslag van mevrouw Maria Fernanda Prado als gedelegeerd bestuurder van de vennootschap met ingang vanaf 1 augustus 2024.",
      "discharge_granted": false
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Nicoleta-Roxana Botea",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-09-01",
      "evidence_quote": "BESLOTEN om Nicoleta-Roxana Botea, met beroepsadres te Antwerpseweg 15-17, 2340 Beerse, te benoemen tot bestuurder van de vennootschap met ingang vanaf 1 september 2024 en eindigend onmiddellijk na de algemene vergadering die de jaarrekening zal goedkeuren van het boekjaar afgesloten op 31 december "
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Nicoleta-Roxana Botea",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-09-01",
      "evidence_quote": "De raad van bestuur BESLUIT Nicoleta-Roxana Botea, met professioneel adres te Antwerpseweg 15-17, 2340 Beerse, Belgi\u00EB, bevoegdheden van dagelijks bestuur toe te kennen, alsook de bevoegdheid om binnen het kader van het dagelijks bestuur de vennootschap te vertegenwoordigen ten overstaan van derden e"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Luc VAN OEVELEN",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-06-28",
      "evidence_quote": "De algemene vergadering beslist om het volgende mandaat als bestuurder te hernieuwen: Luc VAN OEVELEN, woonstkeuze doende op de zetel van de Vennootschap, voor een periode van 6 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Gert Vandewaerde",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-16",
      "evidence_quote": "AKTE GENOMEN van het ontsiag van Gert Vandewaerde als bestuurder en gedelegeerd bestuurder van de vennootschap met ingang vanaf 16 juni 2023."
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Gert Vandewaerde",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-06-16",
      "evidence_quote": "AKTE GENOMEN van het ontsiag van Gert Vandewaerde als bestuurder en gedelegeerd bestuurder van de vennootschap met ingang vanaf 16 juni 2023."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Benoeming bestuurders en commissaris - Nieuwe vaste vertegenwoordigers van bestuurders - Benoeming voorzitter",
      "value": "Benoeming bestuurders en commissaris - Nieuwe vaste vertegenwoordigers van bestuurders - Benoeming voorzitter",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-05-03",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 03 MEI 2023",
      "value": "03/05/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-03-22",
      "type": "general_meeting",
      "quote": "GEWONE ALGEMENE VERGADERING VAN 22 MAART 2023",
      "value": "22/03/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. AstraZeneca N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 2. Bristol-Myers Squibb Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 3.GlaxoSmithKline Pharmaceuticals N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 4.Janssen-Cilag N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 5.Novartis Pharma N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 6.Sanofi Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "auditor_appointment",
      "quote": "De Algemene Vergadering bevestigt de herbenoeming voor een periode van drie jaar van de commissaris KPMG Bedrijfsrevisoren BV",
      "value": {
        "role": "commissaris",
        "term": "drie jaar",
        "start_date": "22/03/2023"
      },
      "object": "e1",
      "subject": "e8"
    },
    {
      "date": "2023-01-01",
      "type": "permanent_representative",
      "quote": "UCB Pharma N.V. ... heeft als nieuwe vaste vertegenwoordiger vanaf 01/01/2023 de heer Xavier Hormaechea",
      "value": {
        "start_date": "01/01/2023"
      },
      "object": "e9",
      "subject": "e10"
    },
    {
      "date": "2023-01-19",
      "type": "permanent_representative",
      "quote": "GlaxoSmithKline Pharmaceuticals N.V. ... heeft als nieuwe vaste vertegenwoordiger vanat 19/01/2023 mevrouw Emmanuelle Boishardy",
      "value": {
        "start_date": "19/01/2023"
      },
      "object": "e4",
      "subject": "e12"
    },
    {
      "date": "2023-04-19",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 19 APRIL 2023",
      "value": "19/04/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-04-19",
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 19 april 2023 werd de heer Fr\u00E9d\u00E9ric Clais tot voorzitter van de Raad van Bestuun benoemd.",
      "value": {
        "role": "voorzitter van de Raad van Bestuur",
        "start_date": "2023-04-19"
      },
      "object": "e1",
      "subject": "e14",
      "_value_raw": {
        "role": "voorzitter van de Raad van Bestuur",
        "start_date": "19/04/2023"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "UCB Pharma N.V. (BE 0403.096.168) heeft als nieuwe vaste vertegenwoordiger vanaf 01/01/2023 de heer Xavier Hormaechea in opvolging van de heer Willy Cnops.",
      "value": {
        "end_date": "01/01/2023"
      },
      "object": "e9",
      "subject": "e11"
    },
    {
      "type": "permanent_representative",
      "quote": "GlaxoSmithKline Pharmaceuticals N.V. (BE 0403.066.474) heeft als nieuwe vaste vertegenwoordiger vanat 19/01/2023 mevrouw Emmanuelle Boishardy, in opvolging van mevrouw Sabena Solomon.",
      "value": {
        "end_date": "19/01/2023"
      },
      "object": "e4",
      "subject": "e13"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 2632,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca N.V.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bus 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e3",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium N.V.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e5",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e6",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma N.V.",
      "attrs": {
        "seat": "Medialaan 40 bus 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e7",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e8",
      "kbo": "0419.122.548",
      "kind": "company",
      "name": "KPMG Bedrijfsrevisoren BV",
      "attrs": {
        "seat": "Bourgetlaan 40, 1130 Brussel"
      }
    },
    {
      "id": "e9",
      "kbo": "0403.096.168",
      "kind": "company",
      "name": "UCB Pharma N.V.",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Xavier Hormaechea",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Willy Cnops",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Emmanuelle Boishardy",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Sabena Solomon",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : Nouveaux administrateurs et commissaire - nouveaux repr\u00E9sentants permanents des administrateurs - Nomination pr\u00E9sident",
      "value": "Nouveaux administrateurs et commissaire - nouveaux repr\u00E9sentants permanents des administrateurs - Nomination pr\u00E9sident",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-05-03",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 03 MEI 2023",
      "value": "03/05/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-03-22",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE ORDINAIRE DU 22 MARS 2023",
      "value": "22/03/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1.AstraZeneca S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 2.Bristol-Myers Squibb Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 3.GlaxoSmithKline Pharmaceuticals S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 4.Janssen-Cilag S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 5.Novartis Pharma S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 5.Sanofi Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "auditor_appointment",
      "quote": "L\u0027Assembl\u00E9e g\u00E9n\u00E9rale confirme la reconduction de la nomination pour une p\u00E9riode de trois ans du commissaire KPMG R\u00E9viseurs d\u0027Entreprises SRL",
      "value": {
        "role": "commissaire",
        "term": "trois ans",
        "start_date": null
      },
      "object": "e1",
      "subject": "e8"
    },
    {
      "date": "2023-01-01",
      "type": "permanent_representative",
      "quote": "UCB Pharma N.V. ... a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 01/01/2023 Monsieur Xavier Hormaechea",
      "value": {
        "start_date": "01/01/2023"
      },
      "object": "e9",
      "subject": "e10"
    },
    {
      "date": "2023-01-19",
      "type": "permanent_representative",
      "quote": "GlaxoSmithKline Pharmaceuticals N.V. ... a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 19/01/2023 Madame Emmanuelle Boishardy",
      "value": {
        "start_date": "19/01/2023"
      },
      "object": "e12",
      "subject": "e13"
    },
    {
      "date": "2023-04-19",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 19 AVRIL 2023",
      "value": "19/04/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 19 avril 2023, Monsieur Fr\u00E9d\u00E9ric Clais a \u00E9t\u00E9 d\u00E9sign\u00E9 comme Pr\u00E9sident du Conseil d\u0027administration.",
      "value": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration"
      },
      "object": "e1",
      "subject": "e15",
      "_value_raw": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration",
        "term": null,
        "start_date": null
      }
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 2645,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca S.A.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bte 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e3",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium S.A.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals S.A.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e5",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e6",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma S.A.",
      "attrs": {
        "seat": "Medialaan 40, bte 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e7",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e8",
      "kbo": "0419.122.548",
      "kind": "company",
      "name": "KPMG R\u00E9viseurs d\u0027Entreprises SRL",
      "attrs": {
        "seat": "avenue du Bourget 40, 1130 Bruxelles"
      }
    },
    {
      "id": "e9",
      "kbo": "0403.096.168",
      "kind": "company",
      "name": "UCB Pharma N.V.",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Xavier Hormaechea",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Willy Cnops",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Emmanuelle Boishardy",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Sabena Solomon",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Roel Boons",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "PwC Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering heeft beslist om, op voordracht van de Ondernemingsraad, het mandaat van de commissaris, PwC Bedrijfsrevisoren BV, te hernieuwen voor een termijn van drie boekjaren, waarvan het eerste 2022 is."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Marleen Hoebus",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-11-01",
      "evidence_quote": "De raad van bestuur heeft beslist Marleen Hoebus, Gert Vandewaerde en Luc van Oevelen, allen met professioneel adres te Antwerpseweg 15-17, 2340 Beerse, Belgi\u00EB, bevoegdheden van dagelijks bestuur toe te kennen, alsook de bevoegdheid om binnen het kader van het dagelijks bestuur de vennootschap te ve"
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Gert Vandewaerde",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-11-01",
      "evidence_quote": "De raad van bestuur heeft beslist Marleen Hoebus, Gert Vandewaerde en Luc van Oevelen, allen met professioneel adres te Antwerpseweg 15-17, 2340 Beerse, Belgi\u00EB, bevoegdheden van dagelijks bestuur toe te kennen, alsook de bevoegdheid om binnen het kader van het dagelijks bestuur de vennootschap te ve"
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Luc van Oevelen",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-11-01",
      "evidence_quote": "De raad van bestuur heeft beslist Marleen Hoebus, Gert Vandewaerde en Luc van Oevelen, allen met professioneel adres te Antwerpseweg 15-17, 2340 Beerse, Belgi\u00EB, bevoegdheden van dagelijks bestuur toe te kennen, alsook de bevoegdheid om binnen het kader van het dagelijks bestuur de vennootschap te ve"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonja Willems",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-11-01",
      "evidence_quote": "De vergadering neemt kennis van het ontslag van mevrouw Sonja Willems als bestuurder, gedelegeerd bestuurder en voorzitter van de raad van bestuur van de vennootschap met ingang van 1 november 2021."
    },
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonja Willems",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-11-01",
      "evidence_quote": "De vergadering neemt kennis van het ontslag van mevrouw Sonja Willems als bestuurder, gedelegeerd bestuurder en voorzitter van de raad van bestuur van de vennootschap met ingang van 1 november 2021."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Maria Fernanda De Almeida Prado",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-11-01",
      "evidence_quote": "De vergadering beslist om mevrouw Maria Fernanda De Almeida Prado, met beroepsadres te Antwerpseweg 15-17, 2340 Beerse, te benoemen tot bestuurder van de vennootschap met ingang van 1 november 2021 en eindigend op de datum van de jaarvergadering in het jaar 2027."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonja Willems",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-11-01",
      "evidence_quote": "De raad van bestuur NEEMT AKTE van het ontslag van Sonja Willems als gedelegeerd bestuurder van de vennootschap met ingang van 1 november 2021."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Maria Fernanda Prado",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-11-01",
      "evidence_quote": "De raad van bestuur BESLUIT Maria Fernanda Prado, met professioneel adres te Antwerpseweg 15-17, 2340 Beerse, Belgi\u00EB, bevoegdheden van dagelijks bestuur toe te kennen, alsook de bevoegdheid om binnen het kader van het dagelijks bestuur de vennootschap te vertegenwoordigen ten overstaan van derden en"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonja Willems",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-11-01",
      "evidence_quote": "De raad van bestuur NEEMT AKTE van het ontslag van Sonja Willems als lid en voorzitter van de raad van bestuur van de vennootschap, met ingang van 1 november 2021."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Maria Fernanda Prado",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-11-01",
      "evidence_quote": "De raad van bestuur BESLUIT om in opvolging van Sonja Willems als nieuwe voorzitter van de raad van bestuur Maria Fernanda Prado t\u00E9 benoemen, met ingang van 1 november 2021."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Gert Vandewaerde",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-10-01",
      "evidence_quote": "De vergadering beslist om de heer Gert Vandewaerde, van Belgische nationaliteit, met beroepsadres te Antwerpseweg 15-17, 2340 Beerse, te benoemen tot bestuurder van de vennootschap met ingang van 1 oktober 2021 en eindigend op de datum van de jaarvergadering in het jaar 2027."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Wim De Vos",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-08-09",
      "evidence_quote": "De vergadering neemt kennis van het ontslag van de heer Wim De Vos als bestuurder van de vennootschap met ingang van 9 augustus 2021."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marleen Hoebus",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-08-09",
      "evidence_quote": "De vergadering benoemt tot bestuurder van de vennootschap met ingang van 9 augustus 2021 en eindigend op de datum van de jaarvergadering in het jaar 2027: mevrouw Marleen Hoebus, van Belgische nationaliteit, met beroepsadres te Antwerpseweg 15-17, 2340 Beerse."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Peter D\u0027hondt",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0415283427",
        "name": "PwC Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-06-29",
      "evidence_quote": "De vergadering neemt kennis van de wijziging van de vaste vertegenwoordiger van de commissaris PwC Bedrijfsrevisoren BV in die zin dat Peter D\u0027hondt vanaf heden vervangen wordt door Roel Boons"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Delegatiereglement dagelijks bestuur - Benoeming Voorzitter-Ondervoorzitter Raad van Bestuur - Ontslag algemeen directeur en aanstelling algemeen directeur ad interim - Gewijzigde statuten - Wijzigingen Raad van bestuur",
      "value": "Delegatiereglement dagelijks bestuur - Benoeming Voorzitter-Ondervoorzitter Raad van Bestuur - Ontslag algemeen directeur en aanstelling algemeen directeur ad interim - Gewijzigde statuten - Wijzigingen Raad van bestuur",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-22",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 22/07/2020",
      "value": "2020-07-22",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-13",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 13 JULI 2020",
      "value": "2020-07-13",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-02-19",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 19 FEBRUARI 2020",
      "value": "2020-02-19",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-06-24",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 24 JUNI 2020",
      "value": "2020-06-24",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-05-13",
      "type": "general_meeting",
      "quote": "ALGEMENE VERGADERING VAN 13 MEI 2020",
      "value": "2020-05-13",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "De raad van bestuur neemt akte van het ontslag van mevrouw Catherine Auguste J. Rutteri ... als algemeen directeur van de vereniging. Dit ontslag zal in werking treden op 1 juli 2020.",
      "value": {
        "role": "algemeen directeur",
        "end_date": "2020-07-01"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2020-07-01",
      "type": "officer_appointment",
      "quote": "Met ingang vanaf 1 juli 2020 wordt mevrouw Ann Maria Marcel Ludo Adriaenseri ... aargesteld als algemeen directeur ad interim van de vereniging.",
      "value": {
        "role": "algemeen directeur ad interim",
        "start_date": "2020-07-01"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 24 juni 2020 werd Pfizer ... verkozen tot nieuwe voorzitter van de Raad van Bestuur",
      "value": {
        "role": "Voorzitter Raad van Bestuur"
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "type": "permanent_representative",
      "quote": "met als vaste vertegenwoordiger Karel Van De Sompel",
      "value": null,
      "object": "e4",
      "subject": "e5"
    },
    {
      "type": "officer_appointment",
      "quote": "werd Eli Lilly Benelux ... verkozen tot nieuwe ondervoorzitter van de Raad van Bestuur",
      "value": {
        "role": "Ondervoorzitter Raad van Bestuur"
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "type": "permanent_representative",
      "quote": "met als vaste vertegenwoordiger Fr\u00E9d\u00E9ric Clais",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "type": "officer_appointment",
      "quote": "Benoeming van: 1. AstraZeneca N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e8"
    },
    {
      "type": "permanent_representative",
      "quote": "met als vaste vertegenwoordiger mevrouw Anne-Laure Dreno",
      "value": null,
      "object": "e8",
      "subject": "e9"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. Bristol-Myers Squibb Belgium N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e10"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 2. GlaxoSmithKline Pharmaceuticals N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e11"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 3. Janssen-Cilag N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e12"
    },
    {
      "type": "permanent_representative",
      "quote": "met als nieuwe vaste vertegenwoordiger mevrouw Sonja Willems",
      "value": null,
      "object": "e12",
      "subject": "e13"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 4. Novartis Pharma N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e14"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 5. Sanofi Belgium N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e15"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 6. Merck N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e16"
    },
    {
      "type": "officer_resignation",
      "quote": "Ontslag van: 1. Celgene BVBA",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e17"
    },
    {
      "type": "statute_amendment",
      "quote": "De voorgestelde wijzigingen aan de statuten werden goedgekeurd door de Algemene Vergadering van 13 mei 2020.",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "purpose",
      "quote": "artikel 3. Belangeloos doel - voorwerp ... Het doel van de Vereniging bestaat in de vertegenwoordiging en de verdediging van de morele en stoffelijke belangen van de geneesmiddelenindustrie in het algemeen en van de innovatieve industrie in het bijzonder.",
      "value": "Het doel van de Vereniging bestaat in de vertegenwoordiging en de verdediging van de morele en stoffelijke belangen van de geneesmiddelenindustrie in het algemeen en van de innovatieve industrie in het bijzonder.",
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 83064,
    "truncated": true
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Auguste J. Rutten",
      "attrs": {
        "address": "Emile Van Becelaerelaan 107, 1170 Watermaal-Bosvoorde",
        "birth_date": "1969-01-28",
        "birth_place": "Leuven"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Ann Maria Marcel Ludo Adriaensen",
      "attrs": {
        "address": "Mimosalaan 30, 3191 Hever",
        "birth_date": "1969-07-21",
        "birth_place": "Turnhout"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "company",
      "name": "Pfizer",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Karel Van De Sompel",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "company",
      "name": "Eli Lilly Benelux",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca N.V.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bus 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Anne-Laure Dreno",
      "attrs": {
        "address": "avenue du general de Longueville 43, 1150 Brussel",
        "birth_date": "1972-06-18",
        "birth_place": "Parijs (Frankrijk)"
      }
    },
    {
      "id": "e10",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium N.V.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e11",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e12",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Sonja Willems",
      "attrs": {
        "address": "Kruisstraat 14, 3545 Halen",
        "birth_date": "1960-09-22",
        "birth_place": "Lier"
      }
    },
    {
      "id": "e14",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma N.V.",
      "attrs": {
        "seat": "Medialaan 40 bus 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e15",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e16",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck N.V.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e17",
      "kbo": "0882.012.387",
      "kind": "company",
      "name": "Celgene BVBA",
      "attrs": {
        "seat": "Place du Luxembourg 1, 1420 Braine-L\u0027Alleud"
      }
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Nomination Vice-Pr\u00E9sident Conseil d\u0027administration et d\u00E9signation repr\u00E9sentants permanents des administrateurs",
      "value": "Nomination Vice-Pr\u00E9sident Conseil d\u0027administration et d\u00E9signation repr\u00E9sentants permanents des administrateurs",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-22",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 22/07/2020 - Annexes du Moniteur belge",
      "value": "22/07/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-13",
      "type": "filing",
      "quote": "neergelegd/ontvangen o 713 JULI 2020",
      "value": "13/07/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-02-19",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 19 FEVRIER 2020",
      "value": "19/02/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "Le Conseil d\u0027administration prend acte de la d\u00E9mission de madame Catherine Auguste J. Rutten ... en tant que directeur g\u00E9n\u00E9ral de l\u0027association. Cette d\u00E9mission entrera en vigueur le 1 juillet 2020.",
      "value": {
        "role": "Directeur g\u00E9n\u00E9ral",
        "end_date": "2020-07-01"
      },
      "object": null,
      "subject": "e2"
    },
    {
      "date": "2020-07-01",
      "type": "officer_appointment",
      "quote": "A partir du 1 juillet 2020, madame Ann Maria Marcel Ludo Adriaensen ... a \u00E9t\u00E9 nomm\u00E9e directeur g\u00E9n\u00E9ral ad interim.",
      "value": {
        "role": "Directeur g\u00E9n\u00E9ral ad interim",
        "start_date": "2020-07-01"
      },
      "object": null,
      "subject": "e3"
    },
    {
      "date": "2020-06-24",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 24 JUIN 2020",
      "value": "24/06/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 24 juin 2020, Pfizer ... a \u00E9t\u00E9 \u00E9lue nouveau Pr\u00E9sident du Conseil d\u0027administration",
      "value": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e4"
    },
    {
      "type": "permanent_representative",
      "quote": "Pfizer, avec en tant que repr\u00E9sentant permanent Karel Van De Sompel",
      "value": null,
      "object": "e4",
      "subject": "e5"
    },
    {
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 24 juin 2020 ... Eli Lilly Benelux ... a \u00E9t\u00E9 \u00E9lue nouveau Vice-Pr\u00E9sident du Conseil d\u0027administration.",
      "value": {
        "role": "Vice-Pr\u00E9sident du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e6"
    },
    {
      "type": "permanent_representative",
      "quote": "Eli Lilly Benelux, avec en tant que repr\u00E9sentant permanent Fr\u00E9d\u00E9ric Clais",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "date": "2020-05-13",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE EXTRAORDINAIRE DU 13 MAI 2020",
      "value": "13/05/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_appointment",
      "quote": "Nomination de : 1. AstraZeneca S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e8"
    },
    {
      "type": "permanent_representative",
      "quote": "AstraZeneca S.A. ... avec en tant que repr\u00E9sentant permanent madame Anne-Laure Dreno",
      "value": null,
      "object": "e8",
      "subject": "e9"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : 1. Bristol-Myers Squibb Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e10"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 2. GlaxoSmithKline Pharmaceuticals S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e11"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 3. Janssen-Cilag S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e12"
    },
    {
      "type": "permanent_representative",
      "quote": "Janssen-Cilag S.A. ... avec en tant que nouveau repr\u00E9sentant permanent madame Sonja Willems",
      "value": null,
      "object": "e12",
      "subject": "e13"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 4. Novartis Pharma S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e14"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 5. Sanofi Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e15"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 6. Merck S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e16"
    },
    {
      "type": "officer_resignation",
      "quote": "D\u00E9mission de: 1. Celgene SPRL",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e17"
    },
    {
      "type": "statute_amendment",
      "quote": "Les modifications propos\u00E9es aux statuts ont \u00E9t\u00E9 approuv\u00E9es par l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire du 13 mai 2020. Les statuts modifi\u00E9s sont libell\u00E9s comme suit:",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "purpose",
      "quote": "article 3. But d\u00E9sint\u00E9ress\u00E9 - Objet Le but poursuivi par l\u0027Association consiste en la repr\u00E9sentation et la d\u00E9fense des int\u00E9r\u00EAts moraux et mat\u00E9riels de l\u0027industrie du m\u00E9dicament en g\u00E9n\u00E9ral et de l\u0027industrie des m\u00E9dicaments innovants en particulier.",
      "value": "Le but poursuivi par l\u0027Association consiste en la repr\u00E9sentation et la d\u00E9fense des int\u00E9r\u00EAts moraux et mat\u00E9riels de l\u0027industrie du m\u00E9dicament en g\u00E9n\u00E9ral et de l\u0027industrie des m\u00E9dicaments innovants en particulier. Parmi les activit\u00E9s concr\u00E8tes men\u00E9es par l\u0027Association en vue de la r\u00E9alisation de son but, on trouve notamment: a)un soutien scientifique, administratif, juridique et organisationnel aux membres... b)l\u0027organisation de toutes activit\u00E9s visant \u00E0 favoriser une meilleure compr\u00E9hension des probl\u00E8mes... c)la promotion... d\u0027une efficiente collaboration entre les membres; d)le d\u00E9veloppement de toutes activit\u00E9s... contribuant directement ou indirectement \u00E0 la r\u00E9alisation du but d\u00E9sint\u00E9ress\u00E9 susmentionn\u00E9...",
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 82578,
    "truncated": true
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Auguste J. Rutten",
      "attrs": {
        "address": "avenue Emile Van Becelaere 107, 1170 Watermael-Boitsfort",
        "birth_date": "1969-01-28",
        "birth_place": "Leuven"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Ann Maria Marcel Ludo Adriaensen",
      "attrs": {
        "address": "Mimosalaan 30, 3191 Hever",
        "birth_date": "1969-07-21",
        "birth_place": "Turnhout"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "company",
      "name": "Pfizer",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Karel Van De Sompel",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "company",
      "name": "Eli Lilly Benelux",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca S.A.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bte 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Anne-Laure Dreno",
      "attrs": {
        "address": "avenue du general de Longueville 43, 1150 Bruxelles",
        "birth_date": "1972-06-18",
        "birth_place": "Paris (France)"
      }
    },
    {
      "id": "e10",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium S.A.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e11",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals S.A.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e12",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Sonja Willems",
      "attrs": {
        "address": "Kruisstraat 14, 3545 Halen",
        "birth_date": "1960-09-22",
        "birth_place": "Lier"
      }
    },
    {
      "id": "e14",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma S.A.",
      "attrs": {
        "seat": "Medialaan 40, bte 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e15",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e16",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck S.A.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e17",
      "kbo": "0882.012.387",
      "kind": "company",
      "name": "Celgene SPRL",
      "attrs": {
        "seat": "Place du Luxembourg 1, 1420 Braine-L\u0027Alleud"
      }
    }
  ]
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Peter D\u0027hondt",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0415283427",
        "name": "PricewaterhouseCoopers Bedrijfsrevisoren",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2019-05-27",
      "evidence_quote": "De vergadering beslist de burgerlijke vennootschap onder de vorm van een co\u00F6peratieve vennootschap met beperkte aansprakelijkheid PricewaterhouseCoopers Bedrijfsrevisoren, met maatschappelijke zetel te Woluwe Garden, Woluwedal 18, 1932 Sint-Stevens-Woluwe waarvan het mandaat van rechtswege een einde"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "stage": "completed",
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2019-05-22",
    "filing_date": "2019-05-13",
    "act_kind_objet": "VERRICHTING GELIJKGESTELD MET EEN FUSIE DOOR OVERNEMING"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-04-29",
    "unanimous": null
  },
  "conversion": {
    "effective_date": null,
    "jurisdiction_to": "BE",
    "legal_form_after": "Naamloze vennootschap",
    "jurisdiction_from": "BE",
    "legal_form_before": "Naamloze vennootschap"
  },
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0415.283.427",
        "name": "Janssen-Cilag",
        "role": "acquiring",
        "address": "Antwerpseweg 15-17, 2340 Beerse",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0415.283.427",
        "name": "Actelion Pharmaceuticals Belgium NV",
        "role": "absorbed",
        "address": "Bedrijvenlaan 1, 2800 Mechelen",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "719",
      "726",
      "676, 1\u00B0"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": "2018-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": true,
    "patrimony_description": "Het gehele vermogen van de overgenomen vennootschap wordt overgenomen onder algemene titel, inclusief alle activa, passiva, immateri\u00EBle en materi\u00EBle goederen, en rechten en verplichtingen. De overname vindt plaats in het kader van een verrichting gelijkgesteld aan een fusie door overneming.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "Janssen-Cilag",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0415.283.427",
    "org_name": "Baker \u0026 McKenzie CVBA",
    "person_name": null,
    "org_rep_person_name": "Marie VANDENBRANDE, Sigrid FREDERICKX"
  },
  "summary_narrative": "De buitengewone algemene vergadering van Janssen-Cilag besliste op 29 april 2019 de overname van Actelion Pharmaceuticals Belgium NV in het kader van een verrichting gelijkgesteld aan een fusie door overneming. Het gehele vermogen van de overgenomen vennootschap werd onder algemene titel overgenomen door Janssen-Cilag, zonder uitgifte van nieuwe aandelen. De overname is boekhoudkundig en fiscaal terugwerkend vanaf 1 januari 2019. Het doel van de vennootschap werd gewijzigd om de activiteiten van de overgenomen vennootschap te integreren.",
  "co_filed_documents": [
    "uitgifte van het proces-verbaal",
    "twee volmachten",
    "geco\u00F6rdineerde tekst van statuten"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "stage": "proposal",
  "notary": {
    "name": "Sonja Willems",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2019-03-11",
    "filing_date": "2019-02-27",
    "act_kind_objet": "Onderwerp akte: Fusievoorstel"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-02-21",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0415.283.427",
        "name": "Janssen-Cilag NV",
        "role": "acquiring",
        "address": "Antwerpseweg 15-17, 2340 Beerse",
        "is_foreign": false,
        "legal_form": "NV",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0872.658.916",
        "name": "Actelion Pharmaceuticals Belgium NV",
        "role": "absorbed",
        "address": "Bedrijvenlaan 1, 2800 Mechelen",
        "is_foreign": false,
        "legal_form": "NV",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50",
      "12:75",
      "12:103",
      "719",
      "676, 1\u00B0",
      "682, 1\u00B0",
      "682, 3\u00B0"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": "2018-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Het gehele vermogen, inclusief rechten en verplichtingen, van Actelion Pharmaceuticals Belgium NV zal overgaan op Janssen-Cilag NV. De verrichting omvat de volledige activa en passiva, inclusief farmaceutische producten, onderzoek en ontwikkeling, distributie en marktactiviteiten.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "Janssen-Cilag",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Sonja Willems",
    "org_rep_person_name": null
  },
  "summary_narrative": "Dit fusievoorstel betreft een met fusie gelijkgestelde verrichting tussen Janssen-Cilag NV en Actelion Pharmaceuticals Belgium NV, waarbij Janssen-Cilag de overnemende vennootschap is en Actelion de over te nemen vennootschap. Aangezien Janssen-Cilag al alle aandelen van Actelion bezit, zal de fusie plaatsvinden zonder uitgifte van nieuwe aandelen. De overname is onder voorbehoud van goedkeuring door de buitengewone algemene vergaderingen van aandeelhouders, gepland voor 29 april 2019. De boekhoudkundige retroactiviteit van de verrichting begint op 1 januari 2019.",
  "co_filed_documents": [
    "Fusievoorstel"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Luc Van Oevelen",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2018-05-28",
      "evidence_quote": "De vergadering beslist om de heer Luc Van Oevelen wiens mandaat verstrijkt op datum van deze jaarvergadering te herbenoemen tot bestuurder van de vennootschap met ingang van heden en eindigend op de datum van de jaarvergadering in het jaar 2024."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0415.283.427",
    "name_full": "JANSSEN-CILAG",
    "legal_form": "NV"
  }
}